Daily non-political popular news in brief.

Potential New Target For Skin Cancer Treatment

When normal skin cells become a melanoma tumor, they sometimes turn on genes not usually found in the skin. According to researchers at the University of Virginia Health System, some of these genes are normally active in the male testis at the time sperm are formed. The genes, called cancer-testis antigens, could be useful targets for drugs that could selectively kill a melanoma tumor, while sparing the rest of the body's tissues.

Read more »

Keywords: potential, target, skin, cancer, treatment

« Previous | Next »

Similar news on "Potential New Target For Skin Cancer Treatment":

1. Infectious disease researchers develop basis for experimental melanoma treatment
   12-07-2006 · EurekAlert!
   While investigating a fungus known to cause an infection in people with AIDS, two grantees of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, unexpectedly discovered a potential strategy for treating metastatic melanoma, one of the deadliest forms of skin cancer. The treatment approach, which involves combining an antibody with radiation, has since been further developed and is expected to enter early-stage human clinical studies in 2007.
   Similar news · Read more »
   
2. Discoveries thrust cancer-initiating stem cells into a larger role in cancer biology and treatment
   04-18-2007 · EurekAlert!
   Recent discoveries about the role of stem cells in cancer have altered the landscape of cancer research. With each new study, scientists are learning more about cancer-initiating properties of stem cells at organ sites and throughout the body. Increasingly, stem cells are examined as the cause -- and potential target of treatment -- for many, if not all, cancers.
   Similar news · Read more »
   
3. JCI table of contents: Dec. 20, 2007
   12-20-2007 · EurekAlert!
   This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published Dec. 20, 2007, in the JCI: "You can teach an old dog new tricks: antimalarial prevents cancer in mice"; "How an Atkins-like diet can treat epilepsy: Leptin attenuates rodent seizure severity"; "A new potential target in the treatment of a fatal brain disease"; "What AM I? AM is a regulator of vascular system functionality"; and others.
   Similar news · Read more »
   
4. Alzheimer's enzyme acts as a tumor suppressor
   06-07-2007 · EurekAlert!
   Researchers at Burnham Institute for Medical Research ("Burnham") have provided the first evidence that gamma-secretase, an enzyme key to the progression of Alzheimer's, acts as a tumor suppressor by altering the pathway of epidermal growth factor receptor (EGFR), a potential treatment target for cancer. Expedited to publication online by Proceedings of the National Academy of Sciences, these findings reveal a limitation of targeting gamma-secretase for treatment of Alzheimer's and potentially other diseases.
   Similar news · Read more »
   
5. Scientists take next step in understanding potential target for Ovarian cancer treatment
   07-16-2007 · EurekAlert!
   A traffic cop protein in the cell may have an even more important role: transporting a messenger protein that tells components in the nucleus to stop cell growth. Scientists are studying the normal function of a protein called 'km23', the traffic cop protein, because the team previously found altered forms of the protein in 42 percent of tumor tissue samples taken from women with Ovarian cancer. The discovery of this additional role may lead to diagnostic tools and earlier treatments for Ovarian cancer.
   Similar news · Read more »
   
6. Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
   12-31-2007 · EurekAlert!
   Scientists at Jefferson's Kimmel Cancer Center in Philadelphia have found that a signaling protein that is key to prostate cancer cell growth is turned on in nearly all recurrent prostate cancers that are resistant to hormone therapy. If the findings hold up, the protein, called Stat5, may be a specific drug target against an extremely difficult-to-treat cancer.
   Similar news · Read more »
   
7. Human C-reactive protein regulates myeloma tumor cell growth and survival
   09-10-2007 · EurekAlert!
   Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.
   Similar news · Read more »
   
8. New radiation technique can greatly reduce painful skin burns in women with breast cancer
   11-06-2006 · EurekAlert!
   Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia. The study is the first of its kind to show how recent dramatic improvements in radiation treatments directly benefit patients.
   Similar news · Read more »
   
9. A new target for the treatment of breast cancer
   01-11-2007 · EurekAlert!
   The active ingredient in a drug currently being tested to treat rheumatoid arthritis might also one day serve as an effective means of treating one of the deadliest forms of breast cancer. Berkeley Lab researchers have demonstrated that inhibiting the activity of the protease enzyme known as TACE can deprive tumor cells of a key factor needed for their proliferation. TACE is strongly present in a form of breast cancer which responds poorly to current therapies.
   Similar news · Read more »
   
10. Therapeutic peptide frees the protein p73 to kill tumor cells
    03-08-2007 · EurekAlert!
    p53 suppresses tumor development by inducing tumor cell death. However, targeting p53 for the treatment of cancer is confounded by the fact that genetic mutations cause loss or inactivation of p53 in approximately 50 percent of human cancers. Now, a new study indicates that targeting the p53-related protein p73 in mice induces the regression of established tumors of human origin, leading to the suggestion that p73 might be a viable target for developing anticancer therapeutics.
    Similar news · Read more »